BACKGROUND: The APOE epsilon4 allele is an established risk factor for Alzheimer disease (AD), yet findings are mixed for how early its effects are manifest. One reason for the mixed results could be the presence of interaction effects with other AD risk factors. Increasing evidence indicates that testosterone may play a significant role in the development of AD. The aim of the present study was to examine the potential interaction of testosterone and APOE genotype with respect to hippocampal volume in middle age. METHODS: Participants were men from the Vietnam Era Twin Study of Aging (n = 375). The mean age was 55.9 years (range 51-59). Between-group comparisons were performed utilizing a hierarchical linear mixed model that adjusted for the nonindependence of twin data. RESULTS: A significant interaction was observed between testosterone and APOE genotype (epsilon4-negative vs epsilon4-positive). Those with both low testosterone (> or =1 SD below the mean) and an epsilon4-positive status had the smallest hippocampal volumes, although comparisons with normal testosterone groups were not significant. However, individuals with low testosterone and epsilon4-negative status had significantly larger hippocampal volumes relative to all other groups. A main effect of APOE genotype on hippocampal volume was observed, but only when the APOE-by-testosterone interaction was present. CONCLUSIONS: These findings demonstrate an interaction effect between testosterone and the APOE epsilon4 allele on hippocampal volume in middle-aged men, and they may suggest 2 low testosterone subgroups. Furthermore, these results allude to potential gene-gene interactions between APOE and either androgen receptor polymorphisms or genes associated with testosterone production.
BACKGROUND: The APOE epsilon4 allele is an established risk factor for Alzheimer disease (AD), yet findings are mixed for how early its effects are manifest. One reason for the mixed results could be the presence of interaction effects with other AD risk factors. Increasing evidence indicates that testosterone may play a significant role in the development of AD. The aim of the present study was to examine the potential interaction of testosterone and APOE genotype with respect to hippocampal volume in middle age. METHODS:Participants were men from the Vietnam Era Twin Study of Aging (n = 375). The mean age was 55.9 years (range 51-59). Between-group comparisons were performed utilizing a hierarchical linear mixed model that adjusted for the nonindependence of twin data. RESULTS: A significant interaction was observed between testosterone and APOE genotype (epsilon4-negative vs epsilon4-positive). Those with both low testosterone (> or =1 SD below the mean) and an epsilon4-positive status had the smallest hippocampal volumes, although comparisons with normal testosterone groups were not significant. However, individuals with low testosterone and epsilon4-negative status had significantly larger hippocampal volumes relative to all other groups. A main effect of APOE genotype on hippocampal volume was observed, but only when the APOE-by-testosterone interaction was present. CONCLUSIONS: These findings demonstrate an interaction effect between testosterone and the APOE epsilon4 allele on hippocampal volume in middle-aged men, and they may suggest 2 low testosterone subgroups. Furthermore, these results allude to potential gene-gene interactions between APOE and either androgen receptor polymorphisms or genes associated with testosterone production.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: S Beyenburg; M Watzka; H Clusmann; I Blümcke; F Bidlingmaier; C E Elger; B Stoffel-Wagner Journal: Neurosci Lett Date: 2000-11-10 Impact factor: 3.046
Authors: Gloria Bachmann; John Bancroft; Glenn Braunstein; Henry Burger; Susan Davis; Lorraine Dennerstein; Irwin Goldstein; Andre Guay; Sandra Leiblum; Rogerio Lobo; Morris Notelovitz; Raymond Rosen; Philip Sarrel; Barbara Sherwin; James Simon; Evan Simpson; Jan Shifren; Richard Spark; Abdul Traish Journal: Fertil Steril Date: 2002-04 Impact factor: 7.329
Authors: William S Kremen; Elizabeth Prom-Wormley; Matthew S Panizzon; Lisa T Eyler; Bruce Fischl; Michael C Neale; Carol E Franz; Michael J Lyons; Jennifer Pacheco; Michele E Perry; Allison Stevens; J Eric Schmitt; Michael D Grant; Larry J Seidman; Heidi W Thermenos; Ming T Tsuang; Seth A Eisen; Anders M Dale; Christine Fennema-Notestine Journal: Neuroimage Date: 2009-09-26 Impact factor: 6.556
Authors: Terrie Vasilopoulos; William S Kremen; Kathleen Kim; Matthew S Panizzon; Phyllis K Stein; Hong Xian; Michael D Grant; Michael J Lyons; Rosemary Toomey; Lindon J Eaves; Carol E Franz; Kristen C Jacobson Journal: Behav Genet Date: 2011-06-19 Impact factor: 2.805
Authors: Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen Journal: Neuroimage Date: 2011-10-01 Impact factor: 6.556
Authors: Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz Journal: Neurobiol Aging Date: 2013-12-27 Impact factor: 4.673
Authors: Kelly Lambert; Amelia J Eisch; Liisa A M Galea; Gerd Kempermann; Michael Merzenich Journal: Neurosci Biobehav Rev Date: 2019-07-26 Impact factor: 8.989
Authors: M Maggio; E Dall'Aglio; F Lauretani; C Cattabiani; G Ceresini; P Caffarra; G Valenti; R Volpi; A Vignali; G Schiavi; G P Ceda Journal: J Nutr Health Aging Date: 2012-01 Impact factor: 4.075
Authors: Christine Fennema-Notestine; Matthew S Panizzon; Wesley R Thompson; Chi-Hua Chen; Lisa T Eyler; Bruce Fischl; Carol E Franz; Michael D Grant; Amy J Jak; Terry L Jernigan; Michael J Lyons; Michael C Neale; Larry J Seidman; Ming T Tsuang; Hong Xian; Anders M Dale; William S Kremen Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: Matthew S Panizzon; Richard L Hauger; Hong Xian; Kristen Jacobson; Michael J Lyons; Carol E Franz; William S Kremen Journal: Psychoneuroendocrinology Date: 2018-03-09 Impact factor: 4.905
Authors: Anders M Fjell; Håkon Grydeland; Stine K Krogsrud; Inge Amlien; Darius A Rohani; Lia Ferschmann; Andreas B Storsve; Christian K Tamnes; Roser Sala-Llonch; Paulina Due-Tønnessen; Atle Bjørnerud; Anne Elisabeth Sølsnes; Asta K Håberg; Jon Skranes; Hauke Bartsch; Chi-Hua Chen; Wesley K Thompson; Matthew S Panizzon; William S Kremen; Anders M Dale; Kristine B Walhovd Journal: Proc Natl Acad Sci U S A Date: 2015-11-02 Impact factor: 11.205